生存率-话题@MedSci

#生存率#

482篇内容 | 3020人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256824, encodeId=90e8125682483, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：HER2在转移性胃癌中的表达及其对生存率的影响, objectType=article, longId=209151, objectId=483d20915154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=483d20915154, replyNumber=0, likeNumber=93, createdTime=2021-03-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=483d20915154, moduleTitle=JCO：HER2在转移性胃癌中的表达及其对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483d20915154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256825, encodeId=44761256825a7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率, objectType=article, longId=209043, objectId=0f3e20904361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f3e20904361, replyNumber=0, likeNumber=37, createdTime=2021-03-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3e20904361, moduleTitle=Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f3e20904361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256823, encodeId=7365125682331, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率, objectType=article, longId=209021, objectId=04b12090217f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04b12090217f, replyNumber=0, likeNumber=0, createdTime=2021-03-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04b12090217f, moduleTitle=Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04b12090217f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256822, encodeId=29b41256822ef, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联, objectType=article, longId=208918, objectId=f491208918f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f491208918f8, replyNumber=0, likeNumber=67, createdTime=2021-03-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f491208918f8, moduleTitle=Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f491208918f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256821, encodeId=e73a125682161, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol：高风险局部和局部晚期肾细胞癌手术切除后的疾病复发、早期进展和总生存率预测 , objectType=article, longId=208759, objectId=4547208e591f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4547208e591f, replyNumber=0, likeNumber=66, createdTime=2021-03-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4547208e591f, moduleTitle=Eur Urol：高风险局部和局部晚期肾细胞癌手术切除后的疾病复发、早期进展和总生存率预测 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4547208e591f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256820, encodeId=3cf3125682018, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Libtayo提高了宫颈癌患者的生存率！, objectType=article, longId=208450, objectId=9d072084507c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d072084507c, replyNumber=0, likeNumber=87, createdTime=2021-03-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d072084507c, moduleTitle=Libtayo提高了宫颈癌患者的生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d072084507c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256819, encodeId=ba7b12568199c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Radiol:如何可靠地预测经索拉非尼治疗的晚期肝细胞癌生存率, objectType=article, longId=208195, objectId=2b4e208195f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b4e208195f6, replyNumber=0, likeNumber=66, createdTime=2021-03-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b4e208195f6, moduleTitle=Eur Radiol:如何可靠地预测经索拉非尼治疗的晚期肝细胞癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b4e208195f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256818, encodeId=52b6125681874, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=白血病治疗获重大突破，提高30%生存率成为可能！, objectType=article, longId=208181, objectId=5f6c2081818a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6c2081818a, replyNumber=0, likeNumber=94, createdTime=2021-03-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6c2081818a, moduleTitle=白血病治疗获重大突破，提高30%生存率成为可能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6c2081818a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256817, encodeId=6418125681e30, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Radiol：放射组学模型中CT层厚预测非小细胞肺癌生存率的影响, objectType=article, longId=208097, objectId=3c8320809eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c8320809eeb, replyNumber=0, likeNumber=69, createdTime=2021-03-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c8320809eeb, moduleTitle=Eur Radiol：放射组学模型中CT层厚预测非小细胞肺癌生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c8320809eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256816, encodeId=ba6412568162e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？, objectType=article, longId=207979, objectId=7a1420e979e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1420e979e8, replyNumber=0, likeNumber=58, createdTime=2021-03-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1420e979e8, moduleTitle=Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a1420e979e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256815, encodeId=5433125681528, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Radiol:DCE-MRI是否可预测原发性中枢神经系统淋巴瘤的化疗反应和生存率？, objectType=article, longId=207971, objectId=bef420e97185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef420e97185, replyNumber=0, likeNumber=0, createdTime=2021-03-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef420e97185, moduleTitle=Eur Radiol:DCE-MRI是否可预测原发性中枢神经系统淋巴瘤的化疗反应和生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bef420e97185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256814, encodeId=5397125681455, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, objectType=article, longId=207858, objectId=4adc20e8585b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4adc20e8585b, replyNumber=0, likeNumber=0, createdTime=2021-03-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4adc20e8585b, moduleTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4adc20e8585b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256813, encodeId=d988125681391, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析, objectType=article, longId=207348, objectId=628320e3487c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=628320e3487c, replyNumber=0, likeNumber=68, createdTime=2021-02-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=628320e3487c, moduleTitle=Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=628320e3487c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256812, encodeId=1dfc125681294, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, objectType=article, longId=207302, objectId=f64120e302ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f64120e302ed, replyNumber=0, likeNumber=61, createdTime=2021-02-20, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f64120e302ed, moduleTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f64120e302ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256811, encodeId=a62d12568116e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=阿斯利康的Imfinzi无法提高头颈癌患者的总体生存率, objectType=article, longId=207015, objectId=bc7b20e0156f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc7b20e0156f, replyNumber=0, likeNumber=59, createdTime=2021-02-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc7b20e0156f, moduleTitle=阿斯利康的Imfinzi无法提高头颈癌患者的总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc7b20e0156f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256810, encodeId=1319125681071, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率, objectType=article, longId=206674, objectId=c5592066e4d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5592066e4d0, replyNumber=0, likeNumber=0, createdTime=2021-02-04, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5592066e4d0, moduleTitle=JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5592066e4d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256809, encodeId=08a212568090b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO: 纳武利尤单抗治疗晚期NSCLC五年生存率可达化疗的5倍！, objectType=article, longId=205955, objectId=9ddd2059556a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ddd2059556a, replyNumber=0, likeNumber=86, createdTime=2021-01-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ddd2059556a, moduleTitle=JCO: 纳武利尤单抗治疗晚期NSCLC五年生存率可达化疗的5倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ddd2059556a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256808, encodeId=5756125680882, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=治疗形式严峻的头颈癌迎来免疫治疗，其五年生存率即将被刷新, objectType=article, longId=205920, objectId=3fee205920bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fee205920bf, replyNumber=0, likeNumber=0, createdTime=2021-01-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fee205920bf, moduleTitle=治疗形式严峻的头颈癌迎来免疫治疗，其五年生存率即将被刷新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fee205920bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256807, encodeId=3958125680e47, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？, objectType=article, longId=205875, objectId=ec732058e5cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec732058e5cb, replyNumber=0, likeNumber=58, createdTime=2021-01-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec732058e5cb, moduleTitle=日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec732058e5cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256806, encodeId=01f612568066b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Netw Open：阿司匹林的使用与老年患者癌症发病率和生存率的评价, objectType=article, longId=205850, objectId=652d205850c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=652d205850c1, replyNumber=0, likeNumber=96, createdTime=2021-01-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=652d205850c1, moduleTitle=JAMA Netw Open：阿司匹林的使用与老年患者癌症发病率和生存率的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=652d205850c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：HER2在转移性胃癌中的表达及其对生存率的影响

2021-03-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率

2021-03-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：每天几杯咖啡或茶，可改善乳腺癌患者的生存率

2021-03-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联

2021-03-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol：高风险局部和局部晚期肾细胞癌手术切除后的疾病复发、早期进展和总生存率预测

2021-03-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Libtayo提高了宫颈癌患者的生存率！

2021-03-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Radiol:如何可靠地预测经索拉非尼治疗的晚期肝细胞癌生存率

2021-03-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

白血病治疗获重大突破，提高30%生存率成为可能！

2021-03-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Radiol：放射组学模型中CT层厚预测非小细胞肺癌生存率的影响

2021-03-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？

2021-03-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Radiol:DCE-MRI是否可预测原发性中枢神经系统淋巴瘤的化疗反应和生存率？

2021-03-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率

2021-03-05

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析

2021-02-21

仁心济世 (审核中...)

前往app查看评论内容

#生存率#

Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究

2021-02-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

阿斯利康的Imfinzi无法提高头颈癌患者的总体生存率

2021-02-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率

2021-02-04

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO: 纳武利尤单抗治疗晚期NSCLC五年生存率可达化疗的5倍！

2021-01-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

治疗形式严峻的头颈癌迎来免疫治疗，其五年生存率即将被刷新

2021-01-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？

2021-01-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Netw Open：阿司匹林的使用与老年患者癌症发病率和生存率的评价

2021-01-20

科室
- - 订阅+
  - 更多科室
工具
服务